Alexion Pharmaceuticals, Inc. · 1 month ago
Associate Director, Early Commercial Strategy
Gaithersburg, Maryland, United States of America
Full-time
Hybrid
Lead/Staff, Director/Executive
$181K/yr - $271K/yr
5+ years expAlexion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing life-changing medicines. The Associate Director, Early Commercial Strategy will partner with early-stage product teams to shape product profiles, guide clinical development, and build business cases for investment decisions, ensuring alignment with market needs and competitive differentiation.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Shape asset vision, segmentation, positioning, and value proposition while the product profile is incomplete and evolving; drive alignment of TPPs and clinical/regulatory plans to commercial needs
Build data-driven revenue forecasts, scenario analyses, and business cases supporting governance milestones up to Ph3ID; present strategy and trade-offs to TA leadership and governance committees
Lead optimized insight plans to address key outstanding questions (unmet need, usage, burden of disease, payer evidence); synthesize market research and competitive intelligence into actionable recommendations
Coordinate commercial evaluations of internal and external opportunities; collaborate with Business Development to assess in-licensing & acquisition options aligned to the V&I portfolio strategy
Represent the commercial voice on global product teams; influence without authority across Research, Development, Medical Affairs, Pricing & Market Access, Regulatory, BI/Analytics, and Regional Commercial teams
Engage Key External Experts (KEEs), payers, and other stakeholders to validate TPPs, evidence strategies, and market access assumptions; support congress planning and advisory boards as needed
Produce strategic and operational commercial plans for late-stage assets (positioning, segmentation, target markets, pricing corridors, access considerations); ensure readiness for governance reviews and global alignment with G8–12 markets
Evaluate the feasibility, impact, and risks of clinical and commercial options; recommend smart risks and simplifications to accelerate decision-making
Embed patient and HCP needs into asset and portfolio decisions; challenge the status quo to deliver differentiated solutions
Qualification
Required
Bachelor's degree required in Business, Medical, Life Sciences, or related field
5–10 years' experience in healthcare or biopharma, with strong exposure to vaccines and/or immune therapies or adjacent infectious disease areas
Demonstrated experience crafting brand or asset strategy while product understanding is incomplete and evolving
Hands-on experience with product profiling and positioning, forecasting, pricing and reimbursement, market research methodologies, and competitive intelligence
Proven ability to generate sales forecasts and business cases for global assets, including scenario planning and sensitivity analyses
Experience engaging external customers (KEEs, prescribers, payers) and translating insights into development and strategy decisions
Comfortable working in a matrix environment and influencing cross-functionally without formal authority
Strong planning and project management; ability to manage complex multi-stakeholder initiatives
Strategic thinking and decision-making under ambiguity; simplify complexity and prioritize effectively
Leadership and influencing skills with high collaboration across functional and geographic boundaries
Analytical, organizational, and communication skills (written and verbal), including governance-ready presentation capabilities
Ability to gauge feasibility, impact, and risk of programs and bring ideas to action
Preferred
Experience with chronic viral infections such as Hepatitis (e.g., HBV) and Cytomegalovirus (CMV), including market dynamics, clinical endpoints, and evidence requirements
Experience with serious bacterial infections such as C. diff and Staph, including market dynamics, clinical endpoints, and evidence requirements
Graduate business degree (MBA)
Graduate degree in science (MSc or PhD)
Strategy Consulting experience
Experience leading commercial evaluation of Business Development opportunities
Prior global exposure, including US market considerations for pricing, access, and evidence generation
Established relationships with Key External Experts in vaccines, immunology, or infectious diseases
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program
Retirement contribution
401(k) plan
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase